黄山胶囊(002817) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was CNY 143,226,804.73, representing a 41.37% increase compared to CNY 101,310,277.27 in the same period last year[5] - Net profit attributable to shareholders for Q1 2023 was CNY 20,099,932.36, up 43.88% from CNY 13,969,880.23 year-on-year[5] - The net profit excluding non-recurring gains and losses was CNY 17,505,461.75, reflecting a significant increase of 78.84% compared to CNY 9,788,481.93 in the previous year[5] - The company's basic and diluted earnings per share both increased by 40.00%, reaching CNY 0.07 per share[5] - Total operating revenue for the current period reached ¥143,226,804.73, a significant increase of 41.4% compared to ¥101,310,277.27 in the previous period[32] - Net profit for the current period was ¥20,210,432.75, representing a 45.0% increase from ¥13,929,428.55 in the same period last year[33] - The company reported a total profit of ¥23,065,598.15, which is a 52.5% increase from ¥15,154,366.55 in the previous period[33] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to CNY 1,059,728,813.29, a 2.12% increase from CNY 1,037,692,058.04 at the end of the previous year[5] - The total equity attributable to the parent company reached ¥873,820,519.63, up from ¥853,758,112.73, indicating an increase of approximately 2.8%[30] - Total current assets amounted to ¥657,357,073.08, up from ¥618,271,712.89, reflecting a growth of approximately 6.3%[29] - Total liabilities increased slightly to ¥185,355,051.05 from ¥183,481,821.74, showing a growth of about 1%[30] Cash Flow - The net cash flow from operating activities decreased by 168.43%, amounting to -CNY 16,148,615.37, compared to CNY 23,600,068.31 in the same period last year[5] - Cash flow from operating activities showed a net outflow of ¥16,148,615.37, contrasting with a net inflow of ¥23,600,068.31 in the prior period[35] - The company reported a 135.32% increase in net cash flow from investing activities, amounting to CNY 17,693,720, mainly due to the redemption of financial products[22] - The company experienced a significant increase in cash inflow from investment activities, totaling ¥46,183,201.83, compared to a net outflow of -¥130,754,044.31 in the previous period[36] - The net increase in cash and cash equivalents was CNY 13,900,880, reflecting a growth of 127.47% compared to the previous year[25] - Cash and cash equivalents at the end of the period totaled ¥348,562,527.05, an increase from ¥234,839,284.78 at the end of the previous period[37] Shareholder Information - The total number of common shareholders at the end of the reporting period is 28,152[27] - The largest shareholder, Shandong Lutai Holdings, holds 29.99% of shares, totaling 89,699,541 shares[27] - The number of shares held by the top ten shareholders includes significant stakes from both state-owned and individual investors, with the top two shareholders holding a combined 38.05%[27] Accounts Receivable - Accounts receivable increased by 58.63%, totaling CNY 51,775,800, primarily due to increased sales and delayed collection[9] - Accounts receivable rose to ¥140,080,825.88 from ¥88,304,996.07, indicating an increase of about 58.6%[29] Research and Development - Research and development expenses increased to ¥4,868,433.54, up from ¥3,869,928.41 in the previous period, indicating a focus on innovation[32] Other Information - The company received government subsidies amounting to CNY 2,810,849.06 during the quarter, contributing to its financial performance[6] - The company has not disclosed any new product developments or market expansion strategies in the current report[28] - Other comprehensive income after tax was reported at -¥46,906.81, compared to -¥11,474.97 in the previous period[33]